LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,421,000 | +53.8% | 30,590 | 0.0% | 0.13% | +28.7% |
| Q1 2020 | $2,225,000 | -47.9% | 30,590 | -25.3% | 0.10% | -37.7% |
| Q4 2019 | $4,271,000 | -2.6% | 40,955 | -7.0% | 0.16% | -15.2% |
| Q3 2019 | $4,385,000 | -12.8% | 44,055 | 0.0% | 0.19% | -6.8% |
| Q2 2019 | $5,029,000 | +33.8% | 44,055 | +47.4% | 0.20% | +34.0% |
| Q1 2019 | $3,758,000 | +4.7% | 29,895 | +13.0% | 0.15% | -0.6% |
| Q4 2018 | $3,589,000 | +46.3% | 26,450 | +195.9% | 0.15% | +73.0% |
| Q3 2018 | $2,454,000 | -33.4% | 8,940 | -87.1% | 0.09% | -48.3% |
| Q4 2014 | $3,682,000 | +13.2% | 69,200 | 0.0% | 0.17% | +13.2% |
| Q3 2014 | $3,252,000 | – | 69,200 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |